These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1181 related items for PubMed ID: 15972864

  • 1. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
    Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA, Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators.
    N Engl J Med; 2005 Jun 23; 352(25):2581-8. PubMed ID: 15972864
    [Abstract] [Full Text] [Related]

  • 2. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M, Janiszewski M, Mamcarz A, Cudnoch-Jedrzejewska A, Dłuzniewski M.
    Med Sci Monit; 2009 Jun 23; 15(6):PH40-8. PubMed ID: 19478711
    [Abstract] [Full Text] [Related]

  • 3. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
    Køber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC.
    N Engl J Med; 1995 Dec 21; 333(25):1670-6. PubMed ID: 7477219
    [Abstract] [Full Text] [Related]

  • 4. Ventricular dysfunction and the risk of stroke after myocardial infarction.
    Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, Lamas GA, Moyé LA, Goldhaber SZ, Pfeffer MA.
    N Engl J Med; 1997 Jan 23; 336(4):251-7. PubMed ID: 8995087
    [Abstract] [Full Text] [Related]

  • 5. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
    Teo KK, Mitchell LB, Pogue J, Bosch J, Dagenais G, Yusuf S, HOPE Investigators.
    Circulation; 2004 Sep 14; 110(11):1413-7. PubMed ID: 15353497
    [Abstract] [Full Text] [Related]

  • 6. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
    Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ, DINAMIT Investigators.
    N Engl J Med; 2004 Dec 09; 351(24):2481-8. PubMed ID: 15590950
    [Abstract] [Full Text] [Related]

  • 7. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ, Ottesen MM, Rask-Madsen C, Andersen PK, Rosthøj S, Torp-Pedersen C, Køber L.
    Int J Cardiol; 2005 Sep 30; 104(2):184-9. PubMed ID: 16168812
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction.
    Orn S, Cleland JG, Romo M, Kjekshus J, Dickstein K.
    Am J Med; 2005 Jul 30; 118(7):752-8. PubMed ID: 15989909
    [Abstract] [Full Text] [Related]

  • 10. [Relationship between arrhythmia profile, left ventricular function and sudden death in the post-infarct period of patients resuscitated from heart arrest].
    Auricchio A, Jost S, Ruggiero B, Vitale P, Iacono A.
    Cardiologia; 1990 Apr 30; 35(4):295-302. PubMed ID: 2245429
    [Abstract] [Full Text] [Related]

  • 11. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G.
    N Engl J Med; 2000 Jun 29; 342(26):1937-45. PubMed ID: 10874061
    [Abstract] [Full Text] [Related]

  • 12. Changes in causes of sudden deaths by decade in patients with coronary arterial lesions due to Kawasaki disease.
    Tsuda E, Arakaki Y, Shimizu T, Sakaguchi H, Yoshimura S, Yazaki S, Echigo S.
    Cardiol Young; 2005 Oct 29; 15(5):481-8. PubMed ID: 16164786
    [Abstract] [Full Text] [Related]

  • 13. [Risk of mortality after myocardial infarction: value of heart rate, its variability and left ventricular ejection fraction].
    Copie X, Hnatkova K, Blankoff I, Staunton A, Camm AJ, Malik M.
    Arch Mal Coeur Vaiss; 1996 Jul 29; 89(7):865-71. PubMed ID: 8869248
    [Abstract] [Full Text] [Related]

  • 14. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
    Cleland JG, Erhardt L, Murray G, Hall AS, Ball SG.
    Eur Heart J; 1997 Jan 29; 18(1):41-51. PubMed ID: 9049514
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of either or both left and right bundle branch block at baseline or during follow-up for predicting death in patients following acute myocardial infarction.
    Bogale N, Orn S, James M, McCarroll K, de Luna AB, Dickstein K, OPTIMAAL Investigators.
    Am J Cardiol; 2007 Mar 01; 99(5):647-50. PubMed ID: 17317365
    [Abstract] [Full Text] [Related]

  • 16. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
    Amigoni M, Meris A, Thune JJ, Mangalat D, Skali H, Bourgoun M, Warnica JW, Barvik S, Arnold JM, Velazquez EJ, Van de Werf F, Ghali J, McMurray JJ, Køber L, Pfeffer MA, Solomon SD.
    Eur Heart J; 2007 Feb 01; 28(3):326-33. PubMed ID: 17251259
    [Abstract] [Full Text] [Related]

  • 17. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction.
    Hartikainen JE, Malik M, Staunton A, Poloniecki J, Camm AJ.
    J Am Coll Cardiol; 1996 Aug 01; 28(2):296-304. PubMed ID: 8800101
    [Abstract] [Full Text] [Related]

  • 18. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
    Choy B, Hansen E, Moss AJ, McNitt S, Zareba W, Goldenberg I, Multicenter Automatic Defibrillator Implantation Trial-II Investigators.
    Am J Cardiol; 2010 Mar 01; 105(5):581-6. PubMed ID: 20185000
    [Abstract] [Full Text] [Related]

  • 19. [Arrhythmia risk stratification based on clinical and functional data].
    Rostagno C, Lazzeri C, Gensini GF.
    Ital Heart J Suppl; 2001 Dec 01; 2(12):1270-7. PubMed ID: 11838347
    [Abstract] [Full Text] [Related]

  • 20. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
    Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators.
    N Engl J Med; 2003 Apr 03; 348(14):1309-21. PubMed ID: 12668699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.